Numbers don’t add up

Quote

anonymous

Guest
I can not see how a 28% growth in prescriptions is driving a 67% increase in net. Keep in mind q1 dropped significantly so maybe something went wrong in q1 that wasn’t disclosed? Looking at the portola shareholder lawsuit it seems channel stuffing was a major focus of the lawsuit. My question is the possibility of a stuff in q2 also?
Thoughts?
 






Very well could be a channel stuff as Esperion management was desperate to show some kind of increase in something in 2nd quarter after the 1st quarter debacle. This is right out of Sheldons playbook as the other board members are to incompetent to figure anything out.
 






anonymous said:
I can not see how a 28% growth in prescriptions is driving a 67% increase in net. Keep in mind q1 dropped significantly so maybe something went wrong in q1 that wasn’t disclosed? Looking at the portola shareholder lawsuit it seems channel stuffing was a major focus of the lawsuit. My question is the possibility of a stuff in q2 also?
Thoughts?
Click to expand...

I have been having the same questions. If I do the math Q4 had 13 millon gross and 8.2 million net. this is based on 40,000 prescription at 330 wac, a gtn of 62? Q1 saw 19 million gross and 6.4 million net a gtn of 33%. q2 saw 26 million gross and 10.6 net a 40% gtn. I counted in the 6% price increase here, but no real improvement. the 40% is still below q4 SO WHAT HAPPENED. last point, sheldon mentioned strong demand. Growth rates dropped to 28% from 46% so growth and margin are drying up. What is the real story here?
 






Excellent post on the shady stuff going on at Esperion. Does anyone check the math from these quarterly calls. Its it corruption or incompetence? Probably both. Amazing DS and other lending companies don't check the Esperion math. This is the crap Sheldon was doing at his last gig. You can't massage these numbers anymore and you can't hide the fact this drug is a complete failure. All the Eric's of pharma won't be able to fix this. What a pitiful YTD result.
 






Stock down again today. Floating around 14.00 trying hard to get to 13.00. Last week was rough and the market has responded to Esperions flaccid quarterly report with all the creative accounting that went into it.
 
























Name of post is " Numbers don't add up "!

Well how could the numbers add up when there are no numbers to add for ESPR sales !

Even the Scientific Hired Highly Tenured Customer Facing and noe Lipid Trained Experts, understand this !
 












I can say that my personal territory numbers looked good, compared to the Region and Country. However, as a company, this sucks. Trying to get out before the titanic is shipped, and recruiters wont look at us!
 






anonymous said:
I can say that my personal territory numbers looked good, compared to the Region and Country. However, as a company, this sucks. Trying to get out before the titanic is shipped, and recruiters wont look at us!
Click to expand...

Were you a Scientific Hire ?

If so, use this honor on your job search.

Pharma companies are clamoring for Scientific Hires !
 






Top Bottom
Back
Quote